• Explore /
  • Poster
  • / PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

Abstract Poster

Authors

null

Lauren Christine Harshman

Dana-Farber Cancer Institute, Boston, MA

Lauren Christine Harshman , Maneka Puligandla , Mohamad E. Allaf , David F. McDermott , Charles G. Drake , Sabina Signoretti , David Cella , Rajan T. Gupta , Brian M. Shuch , Primo Lara Jr., Anil Kapoor , Daniel Yick Chin Heng , Bradley Leibovich , M. Dror Michaelson , Toni K. Choueiri , Viraj A. Master , Michael A.S. Jewett , Deb Maskens , Naomi B. Haas , Michael Anthony Carducci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03055013

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr TPS765)

Abstract #

TPS765

Poster Bd #

K21

Abstract Disclosures

Similar Posters

First Author: Naomi B. Haas

First Author: Lauren Christine Harshman

First Author: Lauren Christine Harshman

First Author: Mohamad E. Allaf